Effect of the hypolipidemic drug RMI 14,514 on hepatic ultrastructure of rats.
D000818:Animals; D002784:Cholesterol / Q000097:blood; D005260:Female; D005663:Furans / Q000494:pharmacology*; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008055:Lipids; D008099:Liver / Q000032:analysis / Q000648:ultrastructure*; D008297:Male; D008830:Microbodies / Q000648:ultrastructure; D008870:Microtubules / Q000648:ultrastructure; D051381:Rats
D005663:Furans; D000960:Hypolipidemic Agents; D008055:Lipids; C014289:5-(tetradecyloxy)-2-furancarboxylic acid; D002784:Cholesterol